These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 37466068)
1. Effects of nicorandil on QT prolongation and myocardial damage caused by citalopram in rats. Akturk G; Micili SC; Gursoy Doruk O; Hocaoglu N; Akan P; Ergur BU; Ahmed S; Kalkan S Biotech Histochem; 2023 Nov; 98(7):479-491. PubMed ID: 37466068 [TBL] [Abstract][Full Text] [Related]
2. Effect of the selective mitochondrial KATP channel opener nicorandil on the QT prolongation and myocardial damage induced by amitriptyline in rats. Sahin O; Akturk G; Cilaker Micili S; Gursoy Doruk O; Karapinar F; Hocaoglu N; Ergur BU; Akan P; Tuncok Y; Kalkan S J Pharm Pharmacol; 2023 Mar; 75(3):415-426. PubMed ID: 36527252 [TBL] [Abstract][Full Text] [Related]
3. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study. Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843 [TBL] [Abstract][Full Text] [Related]
4. Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias. Aizawa Y; Uchiyama H; Yamaura M; Nakayama T; Arita M J Electrocardiol; 1998 Apr; 31(2):117-23. PubMed ID: 9588657 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of QT prolongation with serotonin reuptake inhibitors. Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276 [TBL] [Abstract][Full Text] [Related]
6. [Citalopram and QT prolongation]. Alušík Š; Paluch Z Vnitr Lek; 2018; 63(12):952-956. PubMed ID: 29334745 [TBL] [Abstract][Full Text] [Related]
7. Selective mitochondrial KATP channel activation by nicorandil and 3-pyridyl pinacidil results in antiarrhythmic effect in an anesthetized rabbit model of myocardial ischemia/reperfusion. Das B; Sarkar C Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):97-110. PubMed ID: 12731455 [TBL] [Abstract][Full Text] [Related]
8. QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study. van Haelst IM; van Klei WA; Doodeman HJ; Warnier MJ; De Bruin ML; Kalkman CJ; Egberts TC J Clin Psychiatry; 2014 Jan; 75(1):15-21. PubMed ID: 24345304 [TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of the cardiac toxicity of citalopram: part 1. Howland RH J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855 [TBL] [Abstract][Full Text] [Related]
10. The role of adenosine receptors and endogenous adenosine in citalopram-induced cardiovascular toxicity. Oransay K; Hocaoglu N; Buyukdeligoz M; Tuncok Y; Kalkan S Indian J Pharmacol; 2014; 46(4):378-85. PubMed ID: 25097274 [TBL] [Abstract][Full Text] [Related]
11. Should We be Worried About QTc Prolongation Using Citalopram? A Review. Hutton LMJ; Cave AJ; St-Jean R; Banh HL J Pharm Pract; 2017 Jun; 30(3):353-358. PubMed ID: 26763342 [TBL] [Abstract][Full Text] [Related]
12. Citalopram induced torsade de pointes, a rare life threatening side effect. Kanjanauthai S; Kanluen T; Chareonthaitawee P Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753 [TBL] [Abstract][Full Text] [Related]
13. The Effects of the Adenosine Receptor Antagonists on the Reverse of Cardiovascular Toxic Effects Induced by Citalopram In-Vivo Rat Model of Poisoning. Büyükdeligöz M; Hocaoğlu N; Oransay K; Tunçok Y; Kalkan Ş Balkan Med J; 2015 Jul; 32(3):303-8. PubMed ID: 26185720 [TBL] [Abstract][Full Text] [Related]
15. Association between citalopram, escitalopram and QTc prolongation in a real-world geriatric setting. Crépeau-Gendron G; Brown HK; Shorey C; Madan R; Szabuniewicz C; Koh S; Veinish S; Mah L J Affect Disord; 2019 May; 250():341-345. PubMed ID: 30877856 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the risk of QT prolongation among SSRIs. Funk KA; Bostwick JR Ann Pharmacother; 2013 Oct; 47(10):1330-41. PubMed ID: 24259697 [TBL] [Abstract][Full Text] [Related]
18. Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review. Tseng PT; Lee Y; Lin YE; Lin PY Gen Hosp Psychiatry; 2012; 34(2):210.e13-5. PubMed ID: 22133983 [TBL] [Abstract][Full Text] [Related]
19. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Isbister GK; Friberg LE; Stokes B; Buckley NA; Lee C; Gunja N; Brown SG; MacDonald E; Graudins A; Holdgate A; Duffull SB Ann Emerg Med; 2007 Nov; 50(5):593-600, 600.e1-46. PubMed ID: 17719135 [TBL] [Abstract][Full Text] [Related]
20. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose. Isbister GK; Friberg LE; Duffull SB Intensive Care Med; 2006 Jul; 32(7):1060-5. PubMed ID: 16791669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]